AceProbe Technologies (India) Pvt. Ltd

AceProbe has evolved with a team of Biotech professionals and operates in the niche are of genomics that enable our partners to efficiently design and perform experiments, monitor progress, receive and interpret results, making the adoption of technology trivial. Our comprehensive technology platform and system offerings allow access to a multitude of clinical and research data, key analysis modules for both genotype and expression information, and database archiving and processing capabilities. Flexible platform and custom service features for a medium-density, ultra-high-throughput capability, customizable formats etc. make all our offerings unique and enable predictive outcomes for patients, delivering a personalized approach through genetics. AceProbe has developed its proprietary - Personalized Genetic Solutions (PGx®) that identify a patient’s predisposition to major diseases and other therapeutic considerations, which can improve treatment outcomes and quality of life. Our initial solutions have focused upon enhancing the safety and effectiveness of anticoagulation drugs, including two of the world’s most widely prescribed medications for patients at risk of stroke and other serious circulatory problems. These unique and cost effective tests help in significantly reducing adverse effects and other events in patients who could benefit from dosage adjustments or alternative therapies. At AceProbe we offer, personalized genetics solutions in the field of Oncology, Cardiology, Infectious Diseases, Pre-Natal Diagnostics, Nutrition & other genetic disorders. The growing sets of assays offer insights to treat the same condition for different population subsets for aiding improved outcome. We continually strive to assist physicians acquire an extra diagnostic support to determine which drug is best suited for each patient and be able recommend the best course of treatment! Redefining our presence as a leading specialty life science company.